Pharmaceutical companies in the United States by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 44 pharmaceutical companies in the United States ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- TG Therapeutics19.0%
- Median
- 7.16%
- Combined market value
- NOK 36.42T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | NOK 95.6B | NOK 632.52 | 1.88% down | 103% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | NOK 78.9B | NOK 1,138.69 | 1.88% down | 15% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | NOK 46.6B | NOK 827.01 | 1.01% up | 105% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | NOK 78.9B | NOK 1,209.08 | 2.47% down | 45% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | NOK 84.7B | NOK 3,030.98 | 1.87% up | 83% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | NOK 69.9B | NOK 501.69 | 0.27% up | 21% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | NOK 44.2B | NOK 265.37 | 0.62% down | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | NOK 56B | NOK 2,797.39 | 3.94% down | 44% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | NOK 90.4B | NOK 951.80 | 3.77% down | 302% up | ||
| 10 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | NOK 43.9B | NOK 401.37 | 0.48% down | 82% up | ||
| 11 | BridgeBio PharmaBBIO · Health Care | 10.7% | NOK 148.5B | NOK 762.18 | 0.22% up | 15% up | ||
| 12 | ErascaERAS · Health Care | 10.6% | NOK 48.7B | NOK 138.63 | 3.34% up | 387% up | ||
| 13 | Cogent BiosciencesCOGT · Health Care | 10.0% | NOK 47.1B | NOK 270.44 | 0.25% down | 25% down | ||
| 14 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | NOK 60.8B | NOK 931.13 | 3.27% up | 35% up | ||
| 15 | Travere TherapeuticsTVTX · Health Care | 9.96% | NOK 45.2B | NOK 470.88 | 3.86% down | 39% up | ||
| 16 | Oruka TherapeuticsORKA · Health Care | 9.53% | NOK 64.5B | NOK 951.21 | 1.91% up | 233% up | ||
| 17 | PTC TherapeuticsPTCT · Health Care | 9.31% | NOK 47.5B | NOK 568.61 | 3.16% down | 26% down | ||
| 18 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | NOK 89.8B | NOK 3,867.84 | 0.34% down | 28% down | ||
| 19 | Corcept TherapeuticsCORT · Health Care | 8.34% | NOK 69.3B | NOK 633.49 | 4.15% down | 16% down | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | NOK 60.2B | NOK 425.55 | 1.25% up | 8% up | ||
| 21 | VeradermicsMANE · Health Care | 8.03% | NOK 51.2B | NOK 1,212.68 | 0.38% down | 230% up | ||
| 22 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | NOK 116B | NOK 598.79 | 0.02% down | 12% up | ||
| 23 | Definium TherapeuticsDFTX · Health Care | 7.02% | NOK 39.3B | NOK 287.40 | 1.24% up | 176% up | ||
| 24 | Elanco Animal HealthELAN · Health Care | 6.59% | NOK 128.1B | NOK 256.30 | 1.54% down | 18% up | ||
| 25 | InsmedINSM · Health Care | 6.42% | NOK 309B | NOK 1,408.35 | 20.58% up | 27% down | ||
| 26 | Axsome TherapeuticsAXSM · Health Care | 6.20% | NOK 69.6B | NOK 1,322.75 | 1.25% up | 9% down | ||
| 27 | Legend BiotechLEGN · Health Care | 6.13% | NOK 30.4B | NOK 156.96 | 0.92% down | 43% down | ||
| 28 | Summit TherapeuticsSMMT · Health Care | 5.28% | NOK 82.4B | NOK 103.05 | 0.67% up | 35% down | ||
| 29 | United TherapeuticsUTHR · Health Care | 4.31% | NOK 232.1B | NOK 5,450.69 | 3.16% down | 18% up | ||
| 30 | ZoetisZTS · Health Care | 4.12% | NOK 320B | NOK 787.63 | 5.59% down | 34% down | ||
| 31 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | NOK 193B | NOK 1,441.10 | 1.06% down | 66% down | ||
| 32 | Belite BioBLTE · Health Care | 3.40% | NOK 59.8B | NOK 1,472.30 | 3.33% down | 25% up | ||
| 33 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | NOK 72.7B | NOK 208.53 | 2.24% down | 79% up | ||
| 34 | ViatrisVTRS · Health Care | 3.07% | NOK 222.2B | NOK 193.81 | 1.97% down | 90% up | ||
| 35 | PfizerPFE · Health Care | 2.36% | NOK 1.53T | NOK 268.49 | 1.85% down | 10% up | ||
| 36 | Bristol-Myers SquibbBMY · Health Care | 2.29% | NOK 1.16T | NOK 568.76 | 2.05% down | 26% up | ||
| 37 | Royalty PharmaRPRX · Health Care | 2.27% | NOK 379.6B | NOK 660.21 | 1.38% down | 74% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | NOK 931.2B | NOK 9,001.69 | 2.35% down | 22% up | ||
| 39 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | NOK 1.29T | NOK 5,075.94 | 2.94% down | 22% up | ||
| 40 | Abbott LaboratoriesABT · Health Care | 1.10% | NOK 1.75T | NOK 1,012.63 | 0.58% down | 19% down | ||
| 41 | Merck & CoMRK · Health Care | 1.08% | NOK 3.19T | NOK 1,294.77 | 3.61% down | 36% up | ||
| 42 | AbbVieABBV · Health Care | 0.89% | NOK 4.89T | NOK 2,764.25 | 0.86% down | 20% up | ||
| 43 | Eli LillyLLY · Health Care | 0.81% | NOK 11.73T | NOK 13,172.14 | 2.29% down | 28% up | ||
| 44 | Johnson & JohnsonJNJ · Health Care | 0.71% | NOK 6.27T | NOK 2,604.36 | 2.04% down | 31% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7491 NOK).
Questions and answers
Which pharmaceutical companies in the United States rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 44 pharmaceutical companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by short interest.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by short interest have a combined market value of NOK 36.42T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by short interest”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.